%0 Journal Article
%T Evaluation of the maternal systemic immune system during frozen euploid embryo transfer according to cycle outcome.
%A Baumgarten SC
%A Wyatt MA
%A Ainsworth AJ
%A Fedyshyn B
%A Van Oort CC
%A Shenoy CC
%A Enninga EAL
%J J Reprod Immunol
%V 164
%N 0
%D 2024 Aug 2
%M 38865895
%F 3.993
%R 10.1016/j.jri.2024.104261
%X Infertility affects 15 % of couples in the US, and many turn to assisted reproductive technologies, including in vitro fertilization and subsequent frozen embryo transfer (FET) to become pregnant. This study aimed to perform a broad assessment of the maternal immune system to determine if there are systemic differences on the day of FET in cycles that result in a live birth compared to those that do not. Women undergoing FET of euploid embryos were recruited and blood was collected on the day of FET as well as at early timepoints in pregnancy. Sixty immune and angiogenic proteins were measured in plasma, and gene expression of 92 immune-response related genes were evaluated in peripheral blood mononuclear cells (PBMCs). We found plasma concentrations of interleukin-13 (IL-13) and macrophage derived chemokine (MDC) were significantly lower on the day of FET in cycles that resulted in a live birth. We also found genes encoding C-C chemokine receptor type 5 (CCR5), CD8 subunit alpha (CD8A) and SMAD family member 3 (SMAD3) were upregulated in PBMCs on the day of FET in cycles that resulted in live birth. Measurements of immune mediators from maternal blood could serve as prognostic markers during FET to guide clinical decision making and further our understanding of implantation failure.